Okazawa; Hitoshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Okazawa; Hitoshi.The latest application filed is for "agent for preventing or treating mild cognitive impairment".

Company Profile

2.4.8

Okazawa; Hitoshi - Tokyo JP
Okazawa; Hitoshi - Kanagawa JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Agent For Preventing Or Treating Mild Cognitive Impairment App 20220296620 - Okazawa; Hitoshi	2022-09-22
Therapeutic Agent For Frontotemporal Lobar Degeneration, Method For Screening Therapeutic Agent For Frontotemporal Lobar Degeneration And Method For Treating Frontotemporal Lobar Degeneration App 20210236532 - Okazawa; Hitoshi	2021-08-05
Methods for treating spinocerebellar ataxia type I using RPA1 Grant 10,989,719 - Okazawa April 27, 2	2021-04-27
Detection Of Alzheimer's Disease (ad), Frontotemporal Lobar Degeneration (ftld), Amyotrophic Lateral Schlerosis (als), Parkinson's Disease (pd), And Dementia With Lewy Bodies (dlb) Indicated By Phosphorylation Of Marcks App 20200408783 - OKAZAWA; Hitoshi	2020-12-31
Antibodies against HMB1, and composition comprising same for treating or preventing alzheimer's disease Grant 10,730,937 - Okazawa , et al.	2020-08-04
Antibodies Against Hmgb1, And Composition Comprising Same For Treating Or Preventing Alzheimer's Disease App 20190211092 - OKAZAWA; Hitoshi ; et al.	2019-07-11
Method For Diagnosis Of Alzheimer's Disease And Frontotemporal Lobar Degeneration, Diagnostic Agent, Therapeutic Agent, And Screening Method For Said Agents App 20170182012 - OKAZAWA; Hitoshi	2017-06-29
Agent For Preventing Or Treating Spinocerebellar Ataxia App 20160252530 - OKAZAWA; Hitoshi	2016-09-01
Gene encoding a protein and preventive/remedy for neurodegenerative diseases such as polyglutamine diseases by utilizing the same Grant 7,951,928 - Okazawa May 31, 2	2011-05-31
Prophylactic/therapeutic agent for neurodegenerative disease Grant 7,833,975 - Okazawa November 16, 2	2010-11-16
Prophylactic/therapeutic agent for neurodegenerative disease App 20090280488 - Okazawa; Hitoshi	2009-11-12
Protein and Preventive/Remedy for Neurodegenerative Diseases Such as Polyglutamine Diseases by Utilizing the Same App 20080188408 - Okazawa; Hitoshi	2008-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.